Utilizing database-based enrichment analysis, coupled with in vitro and in vivo pharmacological experiments, we discovered that inhibiting AKT/NLRP3 inflammasome activation attenuated inflammatory responses and pyroptosis, thereby ameliorating RIR-induced acute kidney injury. This evidence concerns the gene NLRP3 and acute kidney injury.